Barclays Remains a Sell on Molina Healthcare (MOH)

In a report released today, Andrew Mok CFA from Barclays maintained a Sell rating on Molina Healthcare, with a price target of $161.00.

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Mok CFA is an analyst with an average return of -5.6% and a 50.55% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Encompass Health, and Radnet.

The word on The Street in general, suggests a Hold analyst consensus rating for Molina Healthcare with a $172.79 average price target.

Based on Molina Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $10.8 billion and a net profit of $14 million. In comparison, last year the company earned a revenue of $11.15 billion and had a net profit of $298 million

Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Most recently, in March 2026, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.